Another driver contributing to the market growth is the growing emphasis on regulatory compliance. Regulatory authorities across the globe are imposing strict guidelines and regulations regarding ...

The quality of water for pharmaceutical production (purified water, water for injection, and ultrapure water) is quantified and regulated through four parameters – total organic carbon (TOC), ...

According to the latest research by Fact.MR., the bioburden testing market is set to witness rapid growth during the forecast period (2021-2031). Rising safety concernss and an increase in number rate ...

Richmond, Feb. 23, 2024 (GLOBE NEWSWIRE) -- According to MarketDigits, the Bioburden Testing Market was valued USD 1.2 Billion in 2023 and projected to reach USD 2.8 Billion by 2030, growing at a CAGR ...

Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...

The Global Bioburden Testing Market has experienced consistent growth, with a compound annual growth rate (CAGR) of 12-15%. This growth is driven by tightening regulatory standards and an increasing ...

Rapid microbiological testing methods, such as the polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), are gaining traction in the bioburden testing industry. These methods ...

The bioburden testing market is projected to experience significant growth due to the increasing demand for quality assurance and safety measures in various industries. The rising awareness about the ...